FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system

BACKGROUND: Two US Food and Drug Administration (FDA)-authorized coronavirus disease 2019 (COVID-19) mRNA vaccines, BNT162b2 (Pfizer/BioNTech) and mRNA-1273 (Moderna), have demonstrated high efficacy in large phase 3 randomized clinical trials. It is important to assess their effectiveness in a real...

Descripción completa

Detalles Bibliográficos
Autores principales: Pawlowski, Colin, Lenehan, Patrick, Puranik, Arjun, Agarwal, Vineet, Venkatakrishnan, A.J., Niesen, Michiel J.M., O’Horo, John C., Virk, Abinash, Swift, Melanie D., Badley, Andrew D., Halamka, John, Soundararajan, Venky
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Clinical Advances
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238652/
https://www.ncbi.nlm.nih.gov/pubmed/34223401
http://dx.doi.org/10.1016/j.medj.2021.06.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238652/
https://www.ncbi.nlm.nih.gov/pubmed/34223401
http://dx.doi.org/10.1016/j.medj.2021.06.007

Ejemplares similares